搜索筛选:
搜索耗时1.7751秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yong Yuan,Shengzhi Wang,Wenmiao Wang,Cheng Zhu,
来源：国际煤炭科学技术学报（英文版） 年份：2021
It is difficult to accurately calculate the lump coal rate in a fully mechanized mining face.Therefore,a numerical simulation of the coal wall cutting process,which revealed the crack expansion,development,evolution in the coal body and the......
[期刊论文] 作者：Cheng Zhu,Yong Yuan,Wenmiao Wang,Zhongshun Chen,Shengzhi Wang,Huiwei Zhong,
来源：矿业科学技术学报:英文版 年份：2021
The\"three shells\"cooperative support technology was proposed herein according to both the large deformation of the rock surrounding large-section chambers in deep mines and the precarious stability of the support structures therein.The de......
[期刊论文] 作者：Cheng Zhu,Yong Yuan,Wenmiao Wang,Zhongshun Chen,Shengzhi Wang,Huiwei Zhong,
来源：矿业科学技术学报（英文版） 年份：2021
The“three shells”cooperative support technology was proposed herein according to both the large defor-mation of the rock surrounding large-section chambers in...
Phase Ⅱ study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative m
[期刊论文] 作者：Anjie Zhu,Peng Yuan,Nanlin Hu,Mingzhou Li,Wenmiao Wang,Xue Wang,Jian Yue,Jiayu Wang,Yang Luo,Fei Ma,Pin,
来源：癌症生物学与医学（英文版） 年份：2021
Objective: Apatinib is an oral TKI targeting VEGFR-2. Single-agent apatinib treatment has been shown to produce an objective response in patients with pretreate...
Phase Ⅱ study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative m
[期刊论文] 作者：Anjie Zhu,Peng Yuan,Nanlin Hu,Mingzhou Li,Wenmiao Wang,Xue Wang,Jian Yue,Jiayu Wang,Yang Luo,Fei Ma,Pin,
来源：癌症生物学与医学:英文版 年份：2021
Objective:Apatinib is an oral TKI targeting VEGFR-2.Single-agent apatinib treatment has been shown to produce an objective response in patients with pretreated m BC.Oral vinorelbine also holds promise as a treatment of choice in patients wi......
相关搜索：
